Bio-Rad Laboratories, Inc. BIO.B
Set alert
At close · Oct 30
After hours · Oct 30, 4:10 PM ET
- YTD
- +22.14%
- 1 year
- +25.19%
- Open
- 379.50
- Prev close
- 379.50
- Mkt cap
- 10.16B
- Vol
- 13
- Avg vol
- 9
- EPS
- 7.89
- P/E
- 48.10
- Div yield
- 0.00%
More statistics
- Low
- 379.50
- High
- 379.50
- Forward P/E
- 33.78
- Beta
- 1.08
- Short ratio
- 0.00
- Inst. own
- 0.08%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 288.90
- 200-d avg
- 292.78
- 1y target
- 0.00
5Y chart
Signals (73)
| Name | Date | Ago |
|---|---|---|
| SMA: Bullish | Oct 26, 2026 | 1 week ago |
| SMA: Bearish | Oct 19, 2026 | 2 weeks ago |
| RSI: Overbought | Aug 17, 2026 | 2 months ago |
| SMA: Bullish | May 25, 2026 | 5 months ago |
| SMA: Bullish | May 25, 2026 | 5 months ago |
| MACD: Buy Signal | May 25, 2026 | 5 months ago |
| SMA: Bearish | May 4, 2026 | 6 months ago |
| SMA: Bearish | May 4, 2026 | 6 months ago |
| MACD: Sell Signal | May 4, 2026 | 6 months ago |
| MACD: Buy Signal | Apr 27, 2026 | 6 months ago |
| SMA: Bullish | Apr 20, 2026 | 6 months ago |
| SMA: Bullish | Mar 30, 2026 | 7 months ago |
| SMA: Bearish | Feb 9, 2026 | 8 months ago |
| RSI: Oversold | Feb 9, 2026 | 8 months ago |
| SMA: Bearish | Feb 2, 2026 | 9 months ago |
| MACD: Sell Signal | Jan 26, 2026 | 9 months ago |
| SMA: Bullish | Jan 19, 2026 | 9 months ago |
| SMA: Bearish | Jan 12, 2026 | 9 months ago |
| SMA: Bullish | Dec 29, 2025 | 10 months ago |
| SMA: Bearish | Dec 22, 2025 | 10 months ago |
| RSI: Overbought | Nov 10, 2025 | 11 months ago |
| RSI: Overbought | Oct 20, 2025 | 1 year ago |
| SMA: Bullish | Sep 15, 2025 | 1 year ago |
| SMA: Bullish | Sep 15, 2025 | 1 year ago |
| SMA: Bearish | Jul 21, 2025 | 1 year ago |
| MACD: Buy Signal | Jun 2, 2025 | 1 year ago |
| SMA: Bullish | May 12, 2025 | 1 year ago |
| RSI: Oversold | Mar 3, 2025 | 1 year ago |
| SMA: Bearish | Feb 10, 2025 | 1 year ago |
| SMA: Bearish | Feb 10, 2025 | 1 year ago |
| MACD: Sell Signal | Feb 10, 2025 | 1 year ago |
| MACD: Buy Signal | Jan 20, 2025 | 1 year ago |
| RSI: Overbought | Jan 20, 2025 | 1 year ago |
| SMA: Bullish | Jan 6, 2025 | 1 year ago |
| SMA: Bearish | Dec 16, 2024 | 1 year ago |
| MACD: Sell Signal | Dec 16, 2024 | 1 year ago |
| RSI: Overbought | Nov 25, 2024 | 1 year ago |
| SMA: Bullish | Jul 29, 2024 | 2 years ago |
| MACD: Buy Signal | Jul 8, 2024 | 2 years ago |
| SMA: Bullish | Jun 17, 2024 | 2 years ago |
| SMA: Bearish | Apr 15, 2024 | 2 years ago |
| SMA: Bearish | Apr 15, 2024 | 2 years ago |
| MACD: Sell Signal | Apr 15, 2024 | 2 years ago |
| RSI: Oversold | Apr 15, 2024 | 2 years ago |
| SMA: Bullish | Apr 8, 2024 | 2 years ago |
| SMA: Bearish | Apr 1, 2024 | 2 years ago |
| SMA: Bullish | Mar 4, 2024 | 2 years ago |
| SMA: Bearish | Feb 26, 2024 | 2 years ago |
| SMA: Bullish | Feb 12, 2024 | 2 years ago |
| MACD: Buy Signal | Dec 18, 2023 | 2 years ago |
| SMA: Bullish | Dec 11, 2023 | 2 years ago |
| MACD: Sell Signal | Sep 25, 2023 | 3 years ago |
| RSI: Oversold | Sep 25, 2023 | 3 years ago |
| SMA: Bearish | Sep 18, 2023 | 3 years ago |
| MACD: Buy Signal | Jul 31, 2023 | 3 years ago |
| SMA: Bullish | Jul 17, 2023 | 3 years ago |
| MACD: Sell Signal | May 15, 2023 | 3 years ago |
| SMA: Bearish | May 8, 2023 | 3 years ago |
| SMA: Bearish | May 8, 2023 | 3 years ago |
| SMA: Bullish | Mar 20, 2023 | 3 years ago |
| SMA: Bullish | Nov 28, 2022 | 3 years ago |
| MACD: Buy Signal | Nov 28, 2022 | 3 years ago |
| SMA: Bearish | Nov 14, 2022 | 3 years ago |
| SMA: Bullish | Nov 7, 2022 | 3 years ago |
| RSI: Oversold | Oct 17, 2022 | 4 years ago |
| MACD: Sell Signal | Sep 26, 2022 | 4 years ago |
| SMA: Bearish | Sep 19, 2022 | 4 years ago |
| RSI: Oversold | Sep 19, 2022 | 4 years ago |
| SMA: Bullish | Aug 1, 2022 | 4 years ago |
| SMA: Bearish | Jun 13, 2022 | 4 years ago |
| RSI: Oversold | Jun 13, 2022 | 4 years ago |
| SMA: Bullish | Jun 6, 2022 | 4 years ago |
| RSI: Oversold | May 2, 2022 | 4 years ago |
Key statistics
- Market cap
- 7.99B
- Enterprise value
- 7.75B
- Trailing P/E
- 49.75
- Forward P/E
- 33.78
- PEG ratio
- 1.21
- Price / sales
- 3.08
- Price / book
- 1.17
- EPS (TTM)
- 6.00
- Beta
- 1.08
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 6.52%
- Revenue (TTM)
- 2.59B
- Revenue growth
- 1.10%
- Free cash flow
- 78.10M
- Total cash
- 1.56B
- Total debt
- 1.38B
- Return on equity
- 2.50%
- Shares outstanding
- 5.06M
- Short % of float
- 0.01%
- 50-day average
- 288.90
- 200-day average
- 292.78
Analyst view
Next earnings
Consensus EPS estimate 0.00.
About Bio-Rad Laboratories, Inc.
Bio-Rad Laboratories, Inc. develops, manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, Latin America, and internationally. It operates through two segments, Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantify biological materials, including cells, proteins, and nucleic acids used in research and biopharmaceutical laboratory environments, as well as for biopharmaceutical manufacturing, quality control process, food safety, and science education applications. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology companies, food producers, and testing laboratories. Its Clinical Diagnostics segment designs, manufactures, markets, and supports diagnostic test systems, informatics systems, test kits, and specialized quality controls for clinical, hospital, diagnostic reference, and transfusion and physician office laboratories, as well as software. The company offers its products through its direct commercial organization, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.
- Sector
- Healthcare
- Industry
- Medical Devices
- Country
- United States
- Employees
- 7,450
- Website
- bio-rad.com
News
No recent headlines
Headlines appear here as they are published.
Your note
Sign in to keep a note on BIO.B — it syncs with the Stock Master app.